In 2012, Mrs Wati was diagnosed with astrocytoma, a type of brain cancer. She underwent surgery and radiation; however, the tumour reappeared and grew, eventually occupying more than half of her right cerebral hemisphere, causing hemiplegia and persistent seizures. Conventional treatment options, such as additional surgery and radiation, were deemed ineffective for her case.
In early December 2013, Mrs Wati turned to an alternative therapy: ECCT as her sole Treatment for Low-Grade Gliomas Brain Cancer. Over time, her condition gradually improved as the tumour mass diminished. After two years of ECCT use, her tumour significantly reduced in size, and the widespread oedema surrounding the initial mass had largely resolved. After five years, she was declared cancer-free. Now, in 2024, Mrs Wati is healthy and cancer-free, marking 10 years since she began ECCT therapy and 12 years since her initial brain cancer diagnosis.
Mrs Wati’s initial brain surgery was performed in October 2012. The pathology report confirmed a malignant tumour, identified as a grade 1 astrocytoma. Following surgery, she underwent 30 sessions of radiation. Her skull bone was not yet replaced at this stage. Approximately six months post-surgery and radiation, MRI results revealed the reappearance of tumours at two locations near the initial site. The new tumour masses measured 2 cm and 4 cm—both larger than the original mass prior to surgery, and the tumour grade seemed to have advanced.
With the recurrence, Mrs Wati’s symptoms worsened progressively. Her seizures became more frequent, and a year after surgery, an MRI showed that the recurrence had expanded to cover more than half of her right cerebral hemisphere, crossing the brain’s midline and pressing against the left hemisphere. The doctors managing her case estimated her life expectancy at less than six months.
Despite undergoing surgery and radiation, the cancer continued to spread. Finally, in early December 2013, Mrs Wati decided to try ECCT. A year post-surgery, before beginning ECCT, Mrs Wati had lost the ability to hold objects with her left hand and could only stand or walk by holding onto support with her right hand. She experienced seizures every one to two weeks.
Having exhausted all conventional medical options, she began ECCT in early December 2013. Initially, she experienced a seizure on the first day, but subsequently, they stopped. Over time, her condition began to improve as the tumour mass gradually reduced. After three months of ECCT, she could walk without support.
After two years, her tumour mass had significantly reduced, and the widespread tumour-related oedema had mostly disappeared. The tumour itself had cleared up entirely after five years of ECCT therapy—a slower progression in keeping with the characteristics of low-grade gliomas treated with ECCT.
Low-grade gliomas tend to respond more slowly to ECCT than higher-grade tumours, such as astrocytomas or glioblastomas. With ECCT, the dead cells undergo lysis, breaking down and exiting the body as mucus, which tends to be slightly sticky due to its high lipid content. If the immune system is strong, this material is excreted as thickened mucus or sticky stool.
In 2024, Mrs Wati marks a significant milestone: 10 years since starting ECCT and 12 years from her original brain cancer diagnosis. She remains healthy, cancer-free, and lives a normal life.
ความคิดเห็น